Home / Intelligence / News

Search

BAIN & COMPANY AND TRINITY LIFE SCIENCES ANNOUNCE STRATEGIC PARTNERSHIP

The partnership pairs Bain’s extensive experience across the global life sciences value chain with Trinity’s specialized, evidence-based solutions for life sciences companies BOSTON, Aug. 8, 2022 /PRNewswire/ — Bain & Company, a top global management consultancy, and Trinity Life Sciences, a leader in global life sciences commercialization solutions, have announced a strategic partnership to bring together Bain’s extensive global experience across the life sciences value chain with Trinity’s deep technical expertise in biopharma and medtech. The partnership includes Bain & Company taking a minority investment…

Read Now

TRINITY LIFE SCIENCES ACQUIRES VANCERY’S CUSTOMER RESEARCH TECHNOLOGY

Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals Waltham, MA, August 4, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery’s customer research technology. The investment expands Trinity’s insights and analytics product offerings, allowing the company to better connect with healthcare professionals to inform commercial strategy for its clients. The new technology will improve primary market research in the life sciences by…

Read Now

TRINITY LIFE SCIENCES ACQUIRES D CUBE ANALYTICS

Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio Waltham, MA, July 19, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more…

Read Now

SIXTY-TWO PERCENT OF BIOPHARMA PRODUCTS THAT LAUNCHED BETWEEN SEPTEMBER 2019 AND DECEMBER 2021 UNDERPERFORMED EXPECTATIONS

Commerical Teams in the Life Sciences Need a Gradual, Stepwise Approach to Product Launches to Achieve Success, according to a New White Paper Available Now from Trinity Life Sciences Waltham, MA, June 29, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that 62 percent of biopharma products that launched between September 2019 and December 2021 underperformed expectations, including 24 out of 28 non-rare, non-oncology products. According to a new white paper entitled Empowering the…

Read Now

FIRST POST PANDEMIC STUDY OF ITS KIND PROVIDES OBJECTIVE DATA TO HELP LIFE SCIENCE COMPANIES MAKE INFORMED DECISIONS ABOUT HOW AND WHERE EMPLOYEES SHOULD WORK

Webinar Entitled “Reimagining Work Models in the Life Sciences: Implications for the Future of Work” Will be Held on June 23 Waltham, MA, June 21, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its latest TGaS report entitled, Reimagining Work Models in the Life Sciences: Implications for the Future of Work. The study is the first of its kind for the life sciences industry as it provides objective data to help companies make informed…

Read Now

NEW ADVISORY BRIEF REVEALS HOW LEADING LIFE SCIENCES COMPANIES CAN INTEGRATE PATIENT CENTRICITY ACROSS THE ORGANIZATION AND PRODUCT LIFECYCLE

“Patient Centricity: Optimizing Integration throughout the Lifecycle” Available Now from Trinity Life Sciences Waltham, MA, June 13, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out the complexities life sciences companies are grappling with as they pull the “idea” of patient centricity through to execution and measurable results. While the vision and goal of patient centricity are clear, the challenge is crafting concrete steps to integrate the patient voice throughout the product lifecycle and…

Read Now

TRINITY LIFE SCIENCES LAUNCHES TGAS ADVISORS’ GOVERNMENT PRICING SERVICES

Sixty-Three Percent of Emerging Life Sciences Companies Outsource Government Pricing Capabilities to a Third-Party Vendor Rather than Implement a System In-House Waltham, MA, June 8, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the launch of Government Pricing (GP) services within TGaS Advisors. The new services help pre-commercial and emerging life sciences companies develop their GP policies and methodologies and provide support for ongoing GP calculations. Because drug pricing in the U.S. remains at…

Read Now

TRINITY LIFE SCIENCES ANNOUNCES THE OPENING OF STATE-OF-THE-ART OFFICE IN INDIA

Office Relocation in Gurgaon Creates Space for Growth and Innovation in the Asia-Pacific Region Gurgaon, India, May 16, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the opening of its next-generation office space in Gurgaon, India. The opening of the new office is part of Trinity’s ongoing commitment to support development and innovation in the Asia-Pacific region. Located near the “cyber hub of India,” the impressive new office boasts sleek contemporary design and state-of-the-art…

Read Now

TRINITY LIFE SCIENCES RANKS AMONG HIGHEST-SCORING BUSINESSES ON INC.’S ANNUAL LIST OF BEST WORKPLACES FOR 2022

Survey Reflects Trinity Employees Trust in Leadership and the Enthusiasm for Professional Growth and Opportunities Waltham, MA, May 11, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has been named to Inc.’s annual Best Workplaces list. Featured in the May/June 2022 issue, hitting newsstands on May 17, 2022, and prominently featured on Inc.com, the list is the result of a comprehensive measurement of American companies that have excelled in creating exceptional workplaces and company culture.…

Read Now

RELEVANCE AND IMPACT OF HEOR GROWING AS COMPLEXITY AND VOLUME OF AVAILABLE REAL-WORLD EVIDENCE CONTINUES TO RISE

New White Paper Entitled “Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR” Available from Trinity Life Sciences Waltham, MA, May 10, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, explores the implications of significant evolution and growth in the U.S. Health Economics and Outcomes Research (HEOR) field over the last decade. Many changes have been driven by payers, regulators and clinicians who are increasingly looking to HEOR and Real-World Evidence…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.